3.01
Microbot Medical Inc stock is traded at $3.01, with a volume of 2.39M.
It is up +3.08% in the last 24 hours and down -25.68% over the past month.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.
See More
Previous Close:
$2.92
Open:
$3.01
24h Volume:
2.39M
Relative Volume:
0.58
Market Cap:
$158.91M
Revenue:
-
Net Income/Loss:
$-10.58M
P/E Ratio:
-2.5083
EPS:
-1.2
Net Cash Flow:
$-9.21M
1W Performance:
-6.52%
1M Performance:
-25.68%
6M Performance:
+34.98%
1Y Performance:
+206.02%
Microbot Medical Inc Stock (MBOT) Company Profile
Name
Microbot Medical Inc
Sector
Industry
Phone
908-938-5561
Address
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Compare MBOT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
MBOT
Microbot Medical Inc
|
3.01 | 154.16M | 0 | -10.58M | -9.21M | -1.20 |
![]()
ISRG
Intuitive Surgical Inc
|
435.73 | 154.00B | 9.15B | 2.63B | 1.99B | 7.1661 |
![]()
BDX
Becton Dickinson Co
|
186.66 | 53.47B | 21.39B | 1.61B | 2.55B | 5.5609 |
![]()
RMD
Resmed Inc
|
273.01 | 39.70B | 5.15B | 1.40B | 1.65B | 9.5082 |
![]()
ALC
Alcon Inc
|
72.60 | 35.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
![]()
WST
West Pharmaceutical Services Inc
|
262.47 | 18.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-13-20 | Reiterated | H.C. Wainwright | Buy |
Dec-24-19 | Reiterated | H.C. Wainwright | Buy |
Jan-31-18 | Initiated | Ladenburg Thalmann | Buy |
Microbot Medical Inc Stock (MBOT) Latest News
Real time scanner hits for Microbot Medical Inc. explainedQuarterly Earnings Report & Fast Exit and Entry Trade Guides - newser.com
Microbot Medical (NASDAQ:MBOT) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Is Microbot Medical Inc. (CY9D) stock at risk of policy regulationMarket Performance Report & Free Expert Approved Momentum Trade Ideas - newser.com
Why Microbot Medical Inc. (CY9D) stock fits value portfolios2025 Year in Review & Smart Allocation Stock Reports - newser.com
What risks investors should watch in Microbot Medical Inc. stockMarket Growth Summary & Expert Curated Trade Ideas - newser.com
Visual trend scoring systems applied to Microbot Medical Inc.2025 Earnings Impact & Technical Entry and Exit Tips - newser.com
How to forecast Microbot Medical Inc. trends using time seriesStop Loss & Technical Pattern Based Signals - newser.com
Using flow based indicators on Microbot Medical Inc.July 2025 Opening Moves & Stock Market Timing Techniques - newser.com
Microbot Medical Inc.’s volatility index tracking explained2025 Historical Comparison & Reliable Trade Execution Plans - newser.com
Will Microbot Medical Inc. rebound enough to break even2025 Market Overview & Fast Gain Swing Alerts - newser.com
Microbot Medical Inc. stock momentum explainedMarket Movers & Fast Entry High Yield Tips - newser.com
Microbot Medical closes stock sale with $29.2M raised - The Robot Report
Microbot Medical Announces Final Closing of Exercise of - GlobeNewswire
Microbot Medical Completes Final Closing of Investment Options - TipRanks
Microbot Medical Inc. Completes Final Closing of Preferred Investment Options, Raising Approximately $25.2 Million - Quiver Quantitative
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds - The Manila Times
Up to $92.2M: Microbot Medical completes final closing of preferred options; $29.2M raised to date - Stock Titan
Will Microbot Medical Inc. (CY9D) stock gain from green policiesJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
Q3 EPS Estimate for Microbot Medical Increased by Analyst - MarketBeat
Microbot Medical Inc. stock prediction for this weekWeekly Trade Recap & Real-Time Stock Movement Alerts - newser.com
Microbot Medical Announces Series H Options Exercise - The Globe and Mail
Microbot Medical (NASDAQ:MBOT) Upgraded at Wall Street Zen - MarketBeat
Microbot Medical issues new equity options and common stock through private placements - Investing.com
Real time alert setup for Microbot Medical Inc. performance2025 Major Catalysts & Fast Gain Swing Trade Alerts - newser.com
Best data tools to analyze Microbot Medical Inc. stockJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com
Microbot Medical receives first Japanese patent for LIBERTY - The Robot Report
Microbot Medical Receives First Patent in Japan as it continues to broaden its Global Intellectual Property Portfolio - MarketScreener
Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio - GlobeNewswire
Microbot Medical®? Receives First Patent in Japan as It Continues to Broaden Its Global Intellectual Property Portfolio - MarketScreener
Microbot Medical receives first patent in Japan for LIBERTY SystemSEC FILING - MarketScreener
Microbot Medical (MBOT) Secures First Patent in Japan for LIBERT - GuruFocus
Microbot Medical secures patent in Japan for Liberty endovascular robotic system - Vascular News
Microbot Medical Secures First Japanese Patent for LIBERTY® - TipRanks
Microbot Medical Inc. Expands Focus on U.S. Market Following Patent Grant in Japan and FDA Clearance for LIBERTY® System - Quiver Quantitative
Robotic Surgery Breakthrough: Microbot Medical's LIBERTY System Wins Japan Patent, Eyes 2.5M US Procedures - Stock Titan
Using portfolio simulators with Microbot Medical Inc. includedJuly 2025 Weekly Recap & Low Risk Investment Opportunities - newser.com
Microbot Medical Inc Stock (MBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):